中晚期原發(fā)性肺癌經(jīng)支氣管動(dòng)脈、胸廓內(nèi)動(dòng)脈灌注化療的療效觀察
肺癌,,肺癌;介入放射學(xué);動(dòng)脈灌注;療效,1資料與方法,2結(jié)果,3討論,【參考文獻(xiàn)】
【摘要】 目的 研究支氣管動(dòng)脈灌注化療(BAI)結(jié)合胸廓內(nèi)動(dòng)脈灌注化療(IAI)治療中晚期原發(fā)性肺癌的可行性及臨床價(jià)值。方法 治療組30例Ⅲ、Ⅳ期原發(fā)性肺癌,行BAI+IAI;對(duì)照組28例Ⅲ、Ⅳ期原發(fā)性肺癌,行BAI。通過(guò)對(duì)CT、生活質(zhì)量及生存期等指標(biāo)觀察,比較兩組的臨床療效。結(jié)果 治療組近期有效率73.3%,高于對(duì)照組(46.4%)(P<0.05);且生活質(zhì)量、生存期均有明顯提高。結(jié)論 BAI結(jié)合IAI是一種安全有效的治療方法,能明顯改善中晚期原發(fā)性肺癌患者的生活質(zhì)量,提高近期療效,延長(zhǎng)生存期。【關(guān)鍵詞】 肺癌;介入放射學(xué);動(dòng)脈灌注;療效
Curative effect of chemotherapy on advanced primary carcinoma of lung by bronchial artery infusion plus internal thoracic artery infusion
YANG Zhongcheng,LIU Jingui,HU Da.
Department of Radiology,The First Hospital of Changsha,Changsha 410005,China
【Abstract】 Objective To investigate the feasibility and clinical efficacy of carcinoma of lung treated by bronchial artery infusion (BAI) and internal thoracic artery infusion (IAI).Methods 30 patients (treatment group) with stage Ⅲ and Ⅳ central type carcinoma of lung were treated by BAI+IAI while 28 patients (control group) with the same stages merely treated by BAI.Therapeutic effect was evaluated and compared according to the improvement of the following parameters:CT,life quality and survival span after the treatment.Results The responsive rate in the treatment group (73.3%) was significantly higher than that in the control group (46.4%),the life quality and survival span were raised significantly (P<0.05).Conclusion Carcinoma of lung treated by BAI plus IAI can not only raise the primary efficacy,prolong patients survival span,but also improve the quality of patients lives. ......
您現(xiàn)在查看是摘要頁(yè),全文長(zhǎng) 8643 字符。